Effectiveness of the Continuous Care Model on Quality of Life, Sexual Satisfaction and Function in Bladder Cancer Patients Undergoing Tumor Resection Surgery: A Randomized Control Trial.

Background: Bladder cancer is a global health concern, and while surgery is vital, it often diminishes patient quality of life, notably sexual function. Existing self-care education is insufficient, necessitating a more holistic approach. The Continuous Care Model (CCM), which emphasizes patient empowerment, shows promise. This study investigates a CCM intervention that includes sexual health education to improve quality of life (QoL) and sexual satisfaction in bladder cancer patients.

Methods: This randomized controlled trial enrolled 54 bladder cancer patients undergoing tumor resection surgery in Tehran, Iran (April-September 2024). Participants were randomly assigned to either a CCM intervention group (n = 26) and a control group (n = 28). QoL was assessed using the EORTC QLQ-C30; sexual function and satisfaction were measured using the Larson Sexual Satisfaction Questionnaire, IIEF, and FSFI at baseline and at 1 and 3 months postintervention.

Results: The CCM group demonstrated significantly improved overall QoL (P < .001) and several subscales (physical, emotional, cognitive, fatigue) compared to controls. Sexual satisfaction also improved significantly in the CCM group (P < .001). Sexual function enhanced particularly for males (enhanced orgasm and sexual desire, P = .049, P = .020, respectively). No significant changes in female sexual function were observed, although past medical history (P = .019) and partner's job (P = .017) were significantly associated with female sexual function.

Conclusions: The CCM intervention effectively enhanced QoL, sexual satisfaction, and sexual function particularly in males. Further research is needed to address the unique challenges impacting female patients' sexual function postbladder cancer surgery.